TABLE 2 Chromosomal Losses, Gains and Amplifications Detected by CGH in Cytologic Specimens of Malignant Tumors

From: The Potential Value of Comparative Genomic Hybridization Analysis in Effusion—and Fine Needle Aspiration Cytology

No.

Losses

Gains

Amplifications

1

4q25qter, 8p21pter, 10q, 14, 16q, 17, 18, 19p, 22

3q24qter, 5p, 5q11q14, 8q21qter, 10p

4q11q21

2

X, 4p14q32, 5q13q21, 9p, 9q, 15, 16q, 18q, 22

1q25q31, 2p23pter, 2q35q37, 3q26qter, 5q33qter, 6p, 6q25qter, 8p, 8q11q22, 10p13pter, 14q21qter, 20

8q22qter

3

Xq21q25, 2q22q32, 3p12q13, 3q24q25, 4p14qter, 5p13p14, 5q14q21, 6q11q22, 9p, 12q15q21.1, 13q14q31, 18q21qter, 21q11q21

1p31pter, 2q37, 4p16, 8p, 8q23qter, 9q34, 10q25qter, 11q12q13.1, 11q23, 12q23qter, 14q31qter, 15q22q23, 16p, 16q22qter, 17pterq21, 17q23qter, 18p 19, 20q, 21q22, 22

 

4

Xq21qter, 4p14q32, 9q

1p34p36.1, 3p24p25, 3q13q23, 3q26qter, 8q11q23, 16p, 22

8q23qter, 17q, 20q

5

Xpterq21, 1p32p35, 4, 5q11q21, 6q11q25, 7p14pter, 8p, B42, 11q21q23, 14, 15q11q15, 17, 18q, 21, 22

1q21, 1q32qter, 2p, 3q, 5p, 5q31qter, 6p22pter, 7p11p12, 7q32qter, 8q23qter, 10, 13, 15q26

20

6

X, 4p, 5q13, 9q22qter, 15q14qter, 17, 19p13.3

1p36, 1p13p31, 1q21, 1q22q32, 3p24pter, 3q, 8q, 14q24qter, 18p11.3, 20q

 

7

Xq21qter, 4p14qter, 5q14q22, 13q14q31, 18q

1p36, 3p21.3, 7q32qter, 8q21q22, 9q34, 10q26, 11p11q13, 14q32, 16p12pter, 19, 20 1p36, 8q24, 11q12q13.1, 16p, 19p, 19q, 20q, 22

8q22qter

9

4q11q32, 11q22qter

8pterq12, 8q23qter, 20q, 22

11q11q14

10

1p36, 11q13qter, 16q, 22

Xq23qter, 1q, 12, 16p, 17q12q21, 19p, 19q

 

11

 

1p34pter, 5p14pter, 5q31q34, 8q23qter, 19q, 20q, 21q22

 

12

Y

Xq11q21, Xq21q26, 8q23q24.1, 12p11, 12q11q13, 17q11q12

 

13

6q

  

14

 

1p36, 16p, 17, 19

 
  1. Borderline aberrations reaching the threshold value are printed in italics.